In 2012, together with our research center, the Barcelonaβeta Brain Research Center (BBRC), we announced the main objectives of Alfa, one of the most complex and highly engaged research infrastructures in the world, with a cohort of nearly 2,700 peopleThe aim of Alfa, which is supported by the ”la Caixa” Foundation, is to identify the early pathophysiological characteristics of Alzheimer's disease in order to detect it early and design prevention programmes that delay or stop the onset of symptoms.

This year, a decade ago, we carried out the final evaluation tests to form part of the cohort with more than 3,000 of the 5,000 people who volunteered. Alfa is made up of participants without cognitive alterations, between 45 and 74 years old, mostly direct descendants of people with Alzheimer's.

The Alfa study would not be possible without the commitment of the participants Over the past 10 years, the BBRC has conducted neuroimaging, clinical and/or cognitive tests that have contributed to a better understanding of the biological processes of Alzheimer's. Since the launch of the platform, the BBRC has conducted key research that has demonstrated the relevance of the preclinical stage of Alzheimer's and has made key contributions to scientific knowledge of the disease.

Thanks to the solidarity of the participants, together with that of the partners, donors, and supporting entities and companies, we are getting closer to a future without Alzheimer's.